[Antitumor platinum(II) complexes with substituted 2-aminomethylpyridine ligands]

Arch Pharm (Weinheim). 1991 Oct;324(10):779-84.
[Article in German]

Abstract

Reaction of K2PtCl4 with the substituted 2-aminomethylpyridines 9, 14, and 22 affords the corresponding dichloroplatinum(II) complexes 3-5. Compounds 3 and 22 show remarkable relative binding affinities for the estrogen receptor. Towards the hormone-independent P388-tumor of the CD2F1-mouse the platinum(II) complexes 4 and 5 are weakly active, complex 3 is inactive. Towards the hormone-independent MDA-MB 231-cell line, compounds 3-5, 9, 14, and 22 exhibit no significant antitumor activity. Towards the hormone-dependent MCF-7 cell line, compounds 3-5, 9, 14 show weak antitumor activity, whereas compound 22 exhibits strong inhibition.

Publication types

  • English Abstract

MeSH terms

  • Animals
  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / therapeutic use
  • Leukemia P388 / drug therapy
  • Male
  • Mice
  • Mice, Inbred Strains
  • Organoplatinum Compounds / chemical synthesis*
  • Organoplatinum Compounds / therapeutic use
  • Pyridines / chemical synthesis*
  • Pyridines / therapeutic use

Substances

  • Antineoplastic Agents
  • Organoplatinum Compounds
  • Pyridines